Aware Sets Third Quarter 2024 Webcast for Wednesday, October 30, 2024, at 5:00 p.m. Eastern Time

BURLINGTON, MASS., Oct. 17, 2024 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE), a global biometric platform company that uses data science, machine learning, and artificial intelligence to tackle everyday business and identity challenges through biometrics, will hold a webcast on Wednesday, October 30, 2024, at 5:00 p.m. Eastern time to discuss its financial results for […]

CarGurus To Report Third Quarter 2024 Financial Results

BOSTON, Oct. 17, 2024 (GLOBE NEWSWIRE) — CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, announced it will issue a press release reporting financial results for the third quarter ended September 30, 2024, after the close of the market on November 7, 2024.

Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination

Singapore, Oct. 17, 2024 (GLOBE NEWSWIRE) — Kairous Acquisition Corp. Limited (NASDAQ: KACL, the “Company”), a special purpose acquisition company, announced today that Kairous Asia Limited, the Company’s initial public offering sponsor (“Sponsor”), has deposited into the Company’s trust account (the “Trust Account”) an aggregate of $50,000, in order to extend the period of time

Flywire to Announce Third Quarter 2024 Results on November 7, 2024

BOSTON, Oct. 17, 2024 (GLOBE NEWSWIRE) — Today, Flywire Corporation (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its third quarter 2024 financial results will be released after market close on Thursday, November 7, 2024. Flywire will host a conference call to discuss its third quarter 2024 financial results at 5:00pm

Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial

Clinical Complete Responses Observed in 4 out of 5 Patients in Subset of Patients with Low Grade Disease; Evidence of Bladder Urothelial Field Effect in Non-Target Tumors Favorable Safety Profile Observed; Only Grade 1 Drug-Related Adverse Events Reported in Less Than 10% of Patients Aura Hosting Virtual Urologic Oncology Investor Event with Key Opinion Leaders

ABM Announces Appointment of New General Counsel

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), one of the world’s largest providers of integrated facility services, infrastructure solutions and parking management, today announced the appointment of Miranda Tolar as Executive Vice President and General Counsel effective January 1, 2025. In this critical role for the Company, Tolar will oversee the

Sight Sciences to Report Third Quarter Financial Results on November 7, 2024

MENLO PARK, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced it will report financial results for the third quarter ended September 30, 2024, after the market

UTime Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) — UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets, announced today that on October 10, 2024, the Company received a notification letter from

Hearing Notice – CIRO to Hold a Disciplinary Hearing for Matthew Philip Ewing

A hearing has been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) pursuant to the Investment Dealer and Partially Consolidated Rules in the matter of Matthew Philip Ewing. The hearing is open to the public unless the panel orders otherwise. The decision of the hearing panel will be made available at

Global Compound Feeds and Additives Market to Reach $636.0 Billion by 2029: A Multi-Billion Dollar Industry

“BCC Research Study Forecasts a 3.8% CAGR, with Market Growth from $526.6 Billion in 2024 to $636.0 Billion by 2029, Driven by Rising Demand for High-Quality Animal Nutrition and Feed Supplements” Compound feeds are specialized blends of nutrients and additives that enhance animal growth, health, and productivity. As the world’s population grows, so does the

Scroll to Top